The Effect of Esomeprazole and Fundoplication on Airways
|ClinicalTrials.gov Identifier: NCT00994708|
Recruitment Status : Completed
First Posted : October 14, 2009
Last Update Posted : October 14, 2009
Evaluate the prevalence of bronchial responsiveness (BHR) among patients with gastroesophageal reflux disease (GERD).
Investigate correlation between bronchial reactivity and the severity of GERD, and similarly investigate the correlation between exhaled nitric oxide (NO) and the severity of GERD.
Compare the effects of esomeprazole 40 mg twice daily and Nissen fundoplication on bronchial reactivity, exhaled NO, pulmonary function and quality of life.
|Condition or disease||Intervention/treatment||Phase|
|Airway Responsiveness||Drug: esomeprazole||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||The Effect of Esomeprazole and Nissen Fundoplication on Bronchial Responsiveness, Quality of Life, Exhaled Nitric Oxide and Pulmonary Function in Patients With Gastroesophageal Reflux Disease|
|Study Start Date :||December 2004|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00994708
|Tampere University Hospital|
|Tampere, Finland, 33521|